skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers

Journal Article · · Nature Communications
DOI:https://doi.org/10.1038/ncomms7114· OSTI ID:1245874

A(H1N1)pdm09 influenza A viruses predominated in the 2013–2014 USA influenza season, and although most of these viruses remain sensitive to Food and Drug Administration-approved neuraminidase (NA) inhibitors, alternative therapies are needed. Here we show that monoclonal antibody CD6, selected for binding to the NA of the prototypic A(H1N1)pdm09 virus, A/California/07/2009, protects mice against lethal virus challenge. The crystal structure of NA in complex with CD6 Fab reveals a unique epitope, where the heavy-chain complementarity determining regions (HCDRs) 1 and 2 bind one NA monomer, the light-chain CDR2 binds the neighbouring monomer, whereas HCDR3 interacts with both monomers. This 30-amino-acid epitope spans the lateral face of an NA dimer and is conserved among circulating A(H1N1)pdm09 viruses. These results suggest that the large, lateral CD6 epitope may be an effective target of antibodies selected for development as therapeutic agents against circulating H1N1 influenza viruses.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); Food and Drug Administration and the Centers for Disease Control and Prevention
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1245874
Journal Information:
Nature Communications, Vol. 6, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 66 works
Citation information provided by
Web of Science

References (50)

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera journal December 2014
The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site journal September 2010
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice journal October 2012
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes journal November 2013
Prevention of influenza by targeting host receptors using engineered proteins journal April 2014
Direct Observation of an Enamine Intermediate in Amine Catalysis journal December 2009
Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts journal May 2010
Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase journal August 2008
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
Mechanism of 150-cavity formation in influenza neuraminidase journal July 2011
Antibody Recognition of a Highly Conserved Influenza Virus Epitope journal April 2009
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses journal February 2009
The CCP4 suite programs for protein crystallography journal September 1994
Antigenic structure and variation in an influenza virus N9 neuraminidase. journal January 1987
Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 å resolution and FabE8 to 2.26 å resolution journal August 1998
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Contacts between Influenza Virus N9 Neuraminidase and Monoclonal Antibody NC10 journal September 2002
Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase journal September 1985
Conserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses journal April 2014
Parenteral Peramivir Treatment for Oseltamivir-Resistant 2009 Pandemic Influenza A H1N1 Viruses journal September 2011
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis journal May 2008
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex journal September 1992
Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza: HYPERIMMUNE HUMAN INTRAVENOUS IMMUNOGLOBULIN journal October 2011
Coot model-building tools for molecular graphics journal November 2004
Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98) journal December 2002
An Antibody That Prevents the Hemagglutinin Low pH Fusogenic Transition journal March 2002
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods journal May 2011
New World Bats Harbor Diverse Influenza A Viruses journal October 2013
Three-dimensional structure of a complex of antibody with influenza virus neuraminidase journal March 1987
A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains journal November 2013
The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody journal August 1994
Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 [HON1] influenza virus with monoclonal antibodies journal August 1978
An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex journal February 2006
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids text January 2007
Bayesian Phylogenetics with BEAUti and the BEAST 1.7 journal February 2012
An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses journal January 2011
Universal primer set for the full-length amplification of all influenza A viruses journal December 2001
Hyperimmune IV Immunoglobulin Treatment journal August 2013
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses journal June 2013
Likelihood-enhanced fast translation functions journal March 2005
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11 journal February 2012
H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis journal September 2012
Neuraminidase Inhibitors for Influenza journal September 2005
MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in Ferrets journal February 2011
Pooled Human Immunoglobulin Therapy in Critically Ill Patients With Pandemic 2009 Influenza A(H1N1) Pneumonitis and Immunoglobulin G2 Subclass (IgG2) Deficiency journal December 2010
Use of TLS parameters to model anisotropic displacements in macromolecular refinement journal January 2001
Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold? journal January 2009
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins journal July 2011
Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase. journal January 1994

Cited By (19)

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans posted_content January 2019
Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs journal November 2018
Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus journal March 2019
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype journal June 2018
Influenza virus neuraminidase (NA): a target for antivirals and vaccines journal June 2016
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies. text January 2019
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans. journal January 2020
Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies journal October 2019
Broadly protective human antibodies that target the active site of influenza virus neuraminidase journal October 2019
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. text January 2018
Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice journal December 2019
Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016–2017 Season journal January 2019
Broadly inhibiting antineuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans. text January 2020
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection journal April 2019
Genetic analysis of neuraminidase gene of influenza A(H1N1)pdm09 virus circulating in Southwest India from 2009 to 2012: Genetic Analysis of NA Gene of Influenza A(H1N1)pdm09 Virus journal July 2016
Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection journal February 2017
New options to treat influenza B journal September 2017
Effector mechanisms of influenza-specific antibodies: neutralization and beyond journal September 2018
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies journal April 2019